{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:11:21Z","timestamp":1783987881131,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"LIMPE-DISMOV"},{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AIRALZH FOUNDATION"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51350-z","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:04:03Z","timestamp":1778670243000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spatio-temporal gait signatures across prodromal and early Parkinson\u2019s disease in two independent cohorts"],"prefix":"10.1038","volume":"16","author":[{"given":"Cinzia","family":"Zatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clint","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rizzardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Catania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbin","family":"Romijnders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Purin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Pasolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Galbiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ferini-Strambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Liepelt-Scarfone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Katharina","family":"von Thaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"S\u00fcnkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjarne","family":"Anton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Rizzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Geritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Padovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Maetzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Schaeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pilotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"issue":"12","key":"51350_CR1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30(12), 1591\u20131601 (2015).","journal-title":"Mov. Disord"},{"issue":"2","key":"51350_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging. 24(2), 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"issue":"8","key":"51350_CR3","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower, J. H. et al. Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease. Brain 136(8), 2419\u20132431 (2013).","journal-title":"Brain"},{"issue":"3","key":"51350_CR4","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/ana.25179","volume":"83","author":"Y Chu","year":"2018","unstructured":"Chu, Y. et al. Do subjects with minimal motor features have prodromal Parkinson disease? Ann. Neurol. 83(3), 562\u2013574 (2018).","journal-title":"Ann. Neurol."},{"key":"51350_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.parkreldis.2018.09.011","volume":"64","author":"S Mantri","year":"2019","unstructured":"Mantri, S., Morley, J. F. & Siderowf, A. D. The importance of preclinical diagnostics in Parkinson disease. Parkinsonism Relat. Disord. 64, 20\u201328 (2019).","journal-title":"Parkinsonism Relat. Disord"},{"issue":"5","key":"51350_CR6","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1378\/chest.14-0970","volume":"146","author":"MJ Sateia","year":"2014","unstructured":"Sateia, M. J. International classification of sleep disorders-third edition: highlights and modifications. Chest 146(5), 1387\u20131394 (2014).","journal-title":"Chest"},{"issue":"6","key":"51350_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","volume":"17","author":"D Berg","year":"2021","unstructured":"Berg, D. et al. Prodromal Parkinson disease subtypes - key to understanding heterogeneity. Nat. Rev. Neurol. 17(6), 349\u2013361 (2021).","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"51350_CR8","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1093\/brain\/awz111","volume":"142","author":"SM Fereshtehnejad","year":"2019","unstructured":"Fereshtehnejad, S. M. et al. Evolution of prodromal Parkinson\u2019s disease and dementia with Lewy bodies: A prospective study. Brain 142(7), 2051\u20132067 (2019).","journal-title":"Brain"},{"issue":"8","key":"51350_CR9","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1093\/brain\/awad072","volume":"146","author":"S Joza","year":"2023","unstructured":"Joza, S. et al. Progression of clinical markers in prodromal Parkinson\u2019s disease and dementia with Lewy bodies: A multicentre study. Brain 146(8), 3258\u20133272 (2023).","journal-title":"Brain"},{"issue":"13","key":"51350_CR10","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1002\/mds.25653","volume":"28","author":"EM McDade","year":"2013","unstructured":"McDade, E. M. et al. Subtle gait changes in patients with REM sleep behavior disorder. Mov. Disord. 28(13), 1847\u20131853 (2013).","journal-title":"Mov. Disord"},{"key":"51350_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/bs.pbr.2020.01.003","volume":"252","author":"E Schaeffer","year":"2020","unstructured":"Schaeffer, E., Postuma, R. B. & Berg, D. Prodromal PD: A new nosological entity. Prog Brain Res. 252, 331\u2013356 (2020).","journal-title":"Prog Brain Res."},{"key":"51350_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.euroneuro.2021.03.011","volume":"46","author":"A Iranzo","year":"2021","unstructured":"Iranzo, A. REM sleep behavior disorder predicts Parkinson disease and dementia with Lewy bodies. Eur. Neuropsychopharmacol. 46, 52\u201353 (2021).","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"51350_CR13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/brain\/awaa365","volume":"144","author":"D Arnaldi","year":"2020","unstructured":"Arnaldi, D. et al. Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder. Brain 144(1), 278\u2013287 (2020).","journal-title":"Brain"},{"issue":"11","key":"51350_CR14","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/S1474-4422(10)70216-7","volume":"9","author":"A Iranzo","year":"2010","unstructured":"Iranzo, A. et al. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: A prospective study [corrected]. Lancet Neurol. 9(11), 1070\u20131077 (2010).","journal-title":"Lancet Neurol."},{"issue":"3","key":"51350_CR15","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/brain\/awz030","volume":"142","author":"RB Postuma","year":"2019","unstructured":"Postuma, R. B. et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: A multicentre study. Brain 142(3), 744\u2013759 (2019).","journal-title":"Brain"},{"issue":"8","key":"51350_CR16","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S1474-4422(21)00201-5","volume":"20","author":"Y Dauvilliers","year":"2021","unstructured":"Dauvilliers, Y. Identifying the best biomarkers for \u03b1-synucleinopathies. Lancet Neurol. 20(8), 593\u2013594 (2021).","journal-title":"Lancet Neurol."},{"issue":"8","key":"51350_CR17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1474-4422(21)00176-9","volume":"20","author":"MG Miglis","year":"2021","unstructured":"Miglis, M. G. et al. Biomarkers of conversion to \u03b1-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder. Lancet Neurol. 20(8), 671\u2013684 (2021).","journal-title":"Lancet Neurol."},{"issue":"1","key":"51350_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41531-025-00897-1","volume":"11","author":"M Mancini","year":"2025","unstructured":"Mancini, M. et al. Digital gait biomarkers in Parkinson\u2019s disease: susceptibility\/risk, progression, response to exercise, and prognosis. NPJ Parkinsons Dis. 11(1), 51 (2025).","journal-title":"NPJ Parkinsons Dis."},{"issue":"3","key":"51350_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ana.25548","volume":"86","author":"S Del Din","year":"2019","unstructured":"Del Din, S. et al. Gait analysis with wearables predicts conversion to parkinson disease. Ann. Neurol. 86(3), 357\u2013367 (2019).","journal-title":"Ann. Neurol."},{"issue":"s2","key":"51350_CR20","doi-asserted-by":"publisher","first-page":"S287","DOI":"10.3233\/JPD-230350","volume":"14","author":"W Maetzler","year":"2024","unstructured":"Maetzler, W. et al. Identifying Subtle Motor Deficits Before Parkinson\u2019s Disease is Diagnosed: What to Look for? J. Parkinsons Dis. 14(s2), S287\u2013s296 (2024).","journal-title":"J. Parkinsons Dis."},{"issue":"9","key":"51350_CR21","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1002\/mds.28631","volume":"36","author":"A Mirelman","year":"2021","unstructured":"Mirelman, A. et al. Detecting Sensitive Mobility Features for Parkinson\u2019s Disease Stages Via Machine Learning. Mov. Disord. 36(9), 2144\u20132155 (2021).","journal-title":"Mov. Disord"},{"issue":"7 Suppl 1","key":"51350_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1212\/WNL.0000000000200236","volume":"99","author":"A Mirelman","year":"2022","unstructured":"Mirelman, A., Siderowf, A. & Chahine, L. Outcome Assessment in Parkinson Disease Prevention Trials: Utility of Clinical and Digital Measures. Neurology 99(7 Suppl 1), 52\u201360 (2022).","journal-title":"Neurology"},{"issue":"8","key":"51350_CR23","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1038\/s41591-023-02440-2","volume":"29","author":"AK Schalkamp","year":"2023","unstructured":"Schalkamp, A. K. et al. Wearable movement-tracking data identify Parkinson\u2019s disease years before clinical diagnosis. Nat. Med. 29(8), 2048\u20132056 (2023).","journal-title":"Nat. Med."},{"issue":"s2","key":"51350_CR24","doi-asserted-by":"publisher","first-page":"S287","DOI":"10.3233\/JPD-230350","volume":"14","author":"W Maetzler","year":"2024","unstructured":"Maetzler, W. et al. Identifying subtle motor deficits before parkinson\u2019s disease is diagnosed: What to look for? J. Parkinsons Dis. 14(s2), S287\u2013S296 (2024).","journal-title":"J. Parkinsons Dis."},{"key":"51350_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2018.07.008","volume":"57","author":"MW Creaby","year":"2018","unstructured":"Creaby, M. W. & Cole, M. H. Gait characteristics and falls in Parkinson\u2019s disease: A systematic review and meta-analysis. Parkinsonism Relat. Disord. 57, 1\u20138 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"issue":"7","key":"51350_CR26","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1474-4422(19)30044-4","volume":"18","author":"A Mirelman","year":"2019","unstructured":"Mirelman, A. et al. Gait impairments in Parkinson\u2019s disease. Lancet Neurol. 18(7), 697\u2013708 (2019).","journal-title":"Lancet Neurol."},{"issue":"1","key":"51350_CR27","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/s41598-020-80768-2","volume":"11","author":"APJ Zanardi","year":"2021","unstructured":"Zanardi, A. P. J. et al. Gait parameters of Parkinson\u2019s disease compared with healthy controls: A systematic review and meta-analysis. Sci. Rep. 11(1), 752 (2021).","journal-title":"Sci. Rep."},{"issue":"1","key":"51350_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ana.22165","volume":"69","author":"A Mirelman","year":"2011","unstructured":"Mirelman, A. et al. Gait alterations in healthy carriers of the LRRK2 G2019S mutation. Ann. Neurol. 69(1), 193\u2013197 (2011).","journal-title":"Ann. Neurol."},{"issue":"10","key":"51350_CR29","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/mds.26269","volume":"30","author":"C Curtze","year":"2015","unstructured":"Curtze, C. et al. Levodopa Is a Double-Edged Sword for Balance and Gait in People With Parkinson\u2019s Disease. Mov. Disord. 30(10), 1361\u20131370 (2015).","journal-title":"Mov. Disord"},{"issue":"3","key":"51350_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/mds.26110","volume":"30","author":"B Galna","year":"2015","unstructured":"Galna, B. et al. Progression of gait dysfunction in incident Parkinson\u2019s disease: impact of medication and phenotype. Mov. Disord. 30(3), 359\u2013367 (2015).","journal-title":"Mov. Disord"},{"key":"51350_CR31","first-page":"270","volume":"6","author":"M Schwartze","year":"2015","unstructured":"Schwartze, M. & Kotz, S. A. Regional Interplay for Temporal Processing in Parkinson\u2019s Disease: Possibilities and Challenges. Front. Neurol. 6, 270 (2015).","journal-title":"Front. Neurol."},{"issue":"7","key":"51350_CR32","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.3390\/s21072292","volume":"21","author":"J Welzel","year":"2021","unstructured":"Welzel, J. et al. Step length is a promising progression marker in Parkinson\u2019s disease. Sensors (Basel). 21(7), 2292 (2021).","journal-title":"Sensors (Basel)"},{"key":"51350_CR33","doi-asserted-by":"publisher","first-page":"2110938","DOI":"10.1016\/j.clinph.2025.2110938","volume":"178","author":"A Rizzardi","year":"2025","unstructured":"Rizzardi, A. et al. Cortical inhibitory and facilitatory alterations in the continuum of alpha-synucleinopathies. Clin. Neurophysiol. 178, 2110938 (2025).","journal-title":"Clin. Neurophysiol."},{"issue":"1","key":"51350_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41531-024-00682-6","volume":"10","author":"C Zatti","year":"2024","unstructured":"Zatti, C. et al. Turning alterations detected by mobile health technology in idiopathic REM sleep behavior disorder. NPJ Parkinsons Dis. 10(1), 64 (2024).","journal-title":"NPJ Parkinsons Dis."},{"issue":"1","key":"51350_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/1877718X241305626","volume":"15","author":"M Mancini","year":"2025","unstructured":"Mancini, M. et al. A framework to standardize gait study protocols in Parkinson\u2019s disease. J. Parkinsons Dis. 15(1), 129\u2013139 (2025).","journal-title":"J. Parkinsons Dis."},{"issue":"9","key":"51350_CR36","doi-asserted-by":"publisher","first-page":"095003","DOI":"10.1088\/1361-6579\/ab4023","volume":"40","author":"R Morris","year":"2019","unstructured":"Morris, R. et al. Validity of Mobility Lab (version 2) for gait assessment in young adults, older adults and Parkinson\u2019s disease. Physiol. Meas. 40(9), 095003 (2019).","journal-title":"Physiol. Meas."},{"key":"51350_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12984-016-0115-z","volume":"13","author":"L Donath","year":"2016","unstructured":"Donath, L. et al. Validity and reliability of a portable gait analysis system for measuring spatiotemporal gait characteristics: comparison to an instrumented treadmill. J. Neuroeng. Rehabil. 13, 6 (2016).","journal-title":"J. Neuroeng. Rehabil"},{"key":"51350_CR38","doi-asserted-by":"publisher","first-page":"1041014","DOI":"10.3389\/fneur.2022.1041014","volume":"13","author":"DC Dewey","year":"2022","unstructured":"Dewey, D. C. et al. APDM gait and balance measures fail to predict symptom progression rate in Parkinson\u2019s disease. Front. Neurol. 13, 1041014 (2022).","journal-title":"Front. Neurol."},{"issue":"1","key":"51350_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s42466-025-00426-8","volume":"7","author":"AC Mejia","year":"2025","unstructured":"Mejia, A. C. et al. Consensus on the clinical utility of digital mobility outcomes for personalized clinical decision support in parkinson\u2019s disease. Neurol. Res. Pract. 7(1), 66 (2025).","journal-title":"Neurol. Res. Pract."},{"key":"51350_CR40","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s11357-025-01731-5","volume":"48","author":"M Zimmermann","year":"2025","unstructured":"Zimmermann, M. et al. Impact of lifestyle factors on quantitative motor and cognitive performance: Insights from a longitudinal study on healthy ageing. Geroscience 48, 1259\u20131275 (2025).","journal-title":"Geroscience"},{"issue":"7","key":"51350_CR41","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1007\/s00415-021-10419-7","volume":"268","author":"E Schaeffer","year":"2021","unstructured":"Schaeffer, E. et al. Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson\u2019s Disease. J. Neurol. 268(7), 2506\u20132514 (2021).","journal-title":"J. Neurol."},{"issue":"12","key":"51350_CR42","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1055\/s-0043-1777111","volume":"81","author":"MA Sobreira-Neto","year":"2023","unstructured":"Sobreira-Neto, M. A. et al. REM sleep behavior disorder: update on diagnosis and management. Arq. Neuropsiquiatr. 81(12), 1179\u20131194 (2023).","journal-title":"Arq. Neuropsiquiatr."},{"issue":"12","key":"51350_CR43","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre, M. et al. Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov. Disord. 22(12), 1689\u20131707 (2007). quiz 1837.","journal-title":"Mov. Disord"},{"issue":"9","key":"51350_CR44","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","volume":"19","author":"CG Goetz","year":"2004","unstructured":"Goetz, C. G. et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov. Disord. 19(9), 1020\u20131028 (2004).","journal-title":"Mov. Disord"},{"issue":"4","key":"51350_CR45","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine, Z. S. et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53(4), 695\u2013699 (2005).","journal-title":"J. Am. Geriatr. Soc."},{"issue":"5","key":"51350_CR46","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S1474-4422(19)30397-7","volume":"19","author":"E Warmerdam","year":"2020","unstructured":"Warmerdam, E. et al. Long-term unsupervised mobility assessment in movement disorders. Lancet Neurol. 19(5), 462\u2013470 (2020).","journal-title":"Lancet Neurol."},{"issue":"1","key":"51350_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12877-020-1445-z","volume":"20","author":"J Geritz","year":"2020","unstructured":"Geritz, J. et al. Motor, cognitive and mobility deficits in 1000 geriatric patients: protocol of a quantitative observational study before and after routine clinical geriatric treatment - the ComOn-study. BMC Geriatr. 20(1), 45 (2020).","journal-title":"BMC Geriatr."},{"issue":"9","key":"51350_CR48","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/j.1468-1331.2006.01512.x","volume":"13","author":"H Lahrmann","year":"2006","unstructured":"Lahrmann, H. et al. EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur. J. Neurol. 13(9), 930\u2013936 (2006).","journal-title":"Eur. J. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51350-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51350-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51350-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:03:19Z","timestamp":1783987399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51350-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51350"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51350-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"C.Hansen, A. Rizzardi, M. Catania, R. Romijnders, L. Purin, MP. Pasolini, (A) Galbiati, I. Liepelt, U. Sunkel, (B) Anton, J.Geritz and A-K. Von Thaler report no conflict of interest. (C) Zatti received grant support from Fondazione LIMPE per il Parkinson Onlus \u2013 2024 Young Researchers Award. (D) Berg received grant support from Deutsche Forschungsgemeinschaft, German Parkinson\u2019s Disease Association, BMBF, Parkinson Fonds Deutschland gGmbH, UCB Pharma GmbH, EU, Novartis Pharma GmbH, Lundbeck, Damp foundation, Michael J Fox Foundation, Else-Kr\u00f6ner-Forschungskolleg (EKFK), Jan von Appen Stiftung, Deutsche Parkinsonstiftung, UCB Pharma GmbH, EU; is a member of the advisory board of UCB Pharma GmbH, ACImmune SA, Lilly Germany GmbH and received honoraria from Biogen, UCB Pharma GmbH, Novartis. A. Padovani received grant support from Ministry of Health (MINSAL) and Ministry of Education, Research and University (MIUR), IMI H2020 initiative (IMI2-2018-15-06). W. Maetzler receives or received funding from the European Union, the German Federal Ministry of Education of Research, German Research Council, Michael J. Fox Foundation, Robert Bosch Foundation, Neuroalliance, Lundbeck, Sivantos and Janssen. He received speaker honoraria from Abbvie, Bayer, BIAL, GlaxoSmithKline, Heel, Licher MT, R\u00f6lke Pharma, Takeda and UCB, was invited to Advisory Boards \/ Consultancies of Abbvie, Aptar Digital Health, Atheneum, BIAL, Biogen, Kyowa Kirin, Lundbeck and Pfizer. He serves as an advisory board member of the Critical Path for Parkinson\u2019s Consortium and the MDS e-Diary Working Group, and as an editorial board member of Geriatric Care. He is a member of the MDS Technology Working Group. (E) Schaeffer received grants from the University of Kiel (intramural research funding) and Germany society for Parkinson\u2019s Disease (DPG e.V.), and speaker honoraria from Bayer Vital GmbH, Novartis Pharma GmbH, BIAL GmbH and the Movement Disorder Society. L. Ferini-Strambi received grant support from Pfizer, Lundbeck, Italfarmaco, Angelini, Bayer, Bioprojet, Jazz Pharma, Idorsia, Bruno Farmaceutici. A. Pilotto received grant support from Airalzh Foundation AGYR2021 Life-Bio Grant, The LIMPE-DISMOV Foundation Segala Grant 2021, the Italian Ministry of University and Research PRIN COCOON (2017MYJ5TH) and PRIN 2021 RePlast, the H2020 IMI IDEA-FAST (ID853981), Italian Ministry of Health, Grant\/Award Number: RF-2018-12366209 and PNRR-Health PNRR-MAD-2022-12376110.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21897"}}